Background: Ceramide is an important messenger of TNF-and lipid-induced apoptosis. We previously demonstrated the adverse effect of TNF in the process of reendothelialization as well as the dependence of its effect on cell-cycle regulation. The current study was designed to investigate the linkage between ceramide induced toxicity and growth arrest in human endothelial cells. concentrations as a result of G1 cell-cycle arrest. Downregulation of cyclin A and p21 protein expression was observed independently of C2-toxicity, while expression of other cell-cycle regulatory genes was not affected. Inhibition of cyclin A protein expression by sequence-specific antisense-oligonucleotides was paralleled by significant growth-inhibition. The protein phosphatase inhibitor okadaic acid induced endothelial cell proliferation, which was completely abrogated by C2. In contrast, aphidicolin-synchronized endothelial cells demonstrated elevated cyclin A levels along with 30% higher BrdU-incorporation and 70% less C2-toxicity. G1-arrested cells, however, showed significantly enhanced C2-toxicity, lack of cyclin A expression and induction of uncleaved caspase-3 (CPP32). Conclusions: Ceramide abrogates endothelial cell proliferation independently of apoptosis or necrosis at low concentrations (#10 mM) through loss of cyclin A expression with subsequent G1 cell-cycle arrest. Synchronization of HAECs in S-phase with aphidicolin overcomes C2-induced G1-arrest and partially blocks ceramide toxicity. These findings demonstrate the dependence of ceramide toxicity on cell cycle regulation, suggesting a strong bidirectional relationship between cell-cycle control and cell death in vessel biology.
Introduction
gene p53 on the one hand serves as a G1 phase checkpoint in the cell-cycle, prohibiting the cell from entering S-phase Apoptosis and cell growth are tightly connected in most for replication of its DNA prior to mitosis [2, 3] . On the cellular systems [1] . Induction of the tumor suppressor other hand, overexpression of p53 induced by hypoxia, oxygen radicals or other noxious stimuli can simultaneously lead to initiation of programmed cell death [4] . Prolifer- [5] [6] [7] as well as in reendothelialization after barotraumatic idium iodide; PMA, phorbol 12-myristate 13-acetate; PP2A, protein vessel injury [8] .
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The enzyme sphingomyelinase (SMase) catalyzes the 1) pAb rabbit, Santa Cruz [sc-126, anti b-actin mAb hydrolysis of sphingomyelin to ceramide and choline mouse, Sigma chemicals [A5441, anti-rabbit IgG-HRP, phosphate [9] . SMase reactions have been implicated in Santa Cruz [sc-2004, anti-mouse IgG-HRP, Santa Cruz specific atherogenic processes [10, 11] , such as hydrolyzing [sc-2005 , and anti-goat IgG-HRP, Santa Cruz [sc-2020. subendothelial LDL. Cultured endothelial cells are an C2-Ceramide (D-erythro-N-acetylsphingosine, BioMol abundant source of SMase [12] .
[SL-100) was dissolved in DMSO (10 mg per 580 ml We have previously shown that neutralizing the physio-DMSO resulting in a 12.5-mM stock solution) and stored logically synthesized cytokine tumor necrosis factor alpha in aliquots at 2208C. Dihydro-C2 (D-erythro-N-acetylsph-(TNF) after experimental balloon angioplasty in a rat inganine, BioMol [SL-101), C6-ceramide (D-erythro-Ncarotid artery model significantly accelerates reenhexanoylsphingosine, BioMol [SL-110) and dihydro-C6 dothelialization of the traumatized vessel [13] . Using an (D-erythro-N-hexanoylsphinganine, BioMol [SL-111) in-vitro model of cultured human endothelial cells we also were also dissolved at 12.5-mM stock solutions in DMSO. found that restoring cyclin A through overexpression of the Okadaic acid and PMA were purchased from Sigma, while transcription factor E2F in TNF-treated cells protected roscovitine, aphidicolin and nocodazole were purchased them from apoptosis. Since ceramide is an important from BioMol. messenger of cell death induced by cytokines [14] , oxysterols [11] and oxygen radicals [15] , this study aimed to 3 further investigate the relationship between growth control 2.3.
[ H]Thymidine incorporation and cell death in human endothelial cells.
To measure DNA synthesis, 15,000 endothelial cells per 35-mm dish were starved for 48 h in EBM2 with 0.5% FCS lacking growth factors. Growth-media and 2. Methods 3 [H]thymidine (3 mCi / ml) were added for selected times up to 44 h. Adherent cultures were fixed with 1 ml of 10% 2.1. Endothelial cell isolation and culture TCA, solubilised in 0.25 N NaOH and then harvested. 3 [H]Thymidine incorporation was determined by liquid Human iliac and renal arteries were obtained from organ scintillation counting. Each sample was done in triplicate, donors (approved by local ethics committee). Human and the data are presented as mean values6S.E.M. of the arterial endothelial cells (HAECs) were isolated and replicates per assay. passaged according to techniques described previously [16] . HAECs were subcultured onto collagen-coated plastic culture dishes (Iwaki Glass) and grown in an endotheli-2.4. BrdU-ELISA al medium kit (EBM2, Clonetics) containing VEGF, hEGF, 3 hFGF, R -IGF-1, hydrocortisone, 2% FCS and 1% penicilBrdU ELISA was performed in 96-well plates. HAECs lin / streptomycin. Subcultured HAECs were characterized were seeded at subconfluent density, and conditions were by immunocytochemical staining with polyclonal antiboadded the next day. Then 10 ml of 10 mM BrdU labeling dies against von Willebrand factor (Boehringer Mannreagent (59bromo-29deoxyuridine) was added 42 h after the heim), and contamination with vascular smooth muscle incubation with the indicated substance had been started. cells was excluded by additional double staining using Another 6 h later, cells were fixed for 45 min at room antibodies against smooth muscle a-actin. Monolayers temperature. Next 100 ml of anti-BrdU antibody in a 1:100 showed characteristic cobblestone morphology. Cells were dilution were added per well and incubated for 90 min at fed every 3rd day and used for experiments in low 378C. After three washing steps peroxidase-substrate solupassages (2 through 4). DAPI staining (Boehringer Manntion (100 ml) was added to each well and the color reaction heim) was performed in order to exclude contamination was stopped after 5 min with 25 ml 1 M H SO . [17] . Endothelial cells were cultured in 100 ml of HAEC the following protease inhibitors: 0.5 mM / l PMSF, 1 medium in 96-well flat bottomed, fibronectin coated culmg / ml aprotinin, 1 mg / ml leupeptin and 0.5 mg / ml ture plates (Becton Dickinson). Cultures were seeded at pepstatin A. After centrifugation at high speed supernatant 3 6310 cells / well for subconfluent conditions. After the was collected and protein content of all samples was indicated time of incubation with the appropriate medium, determined using the Bio-Rad protein assay with g 20 ml of MTS / PMS (1:0.05) mixture was added per well globulin as a standard. and cells were incubated 2 h before measuring absorbance at 490 nm. Background absorbance from the control wells 2.9. Western blot analysis (same medium, no cells) was subtracted. Viability of control cells was set to 100% and cell death was measured Electrophoresis was performed on 12% SDS-polyas 100% -% viability of treated cells. Throughout this acrylamide gels loading 30 mg of protein per lane. After paper, each calculated value for viability or cell death, transfer to a 0.2-mm PVDF membrane (Bio-Rad) memrespectively, is the average of six wells per group.
branes were blocked in 10% (w / v) non-fat dry milk (in PBS, pH 7.5, and 0.1% Tween 20) for 1 h and incubated for 150 min with the monoclonal or polyclonal antibodies 2.6. Flow cytometry for measurement of cell-cycle at 48C. Each antibody incubation period was followed by 1 distribution h of membrane washing in 0.1% Tween-20 in PBS. Detection was carried out by use of a secondary Adherent cells were detached by trypsinization (0.05% horseradish peroxidase-linked anti-rabbit (1:7500 in PBS / (w / v) trypsin in 0.02% (w / v) EDTA in HBSS), incubated 1% Tween 20 / 2% non-fat milk) or anti-mouse (1:5000 in for 5 min at 378C, and harvested. After washing once in PBS / 1% Tween 20 / 2% non-fat milk) antibody (Santa PBS and slow centrifugation (4003g) the pellet was Cruz) and the Amersham enhanced chemiluminescence resuspended in ice cold ethanol (70%) and fixed overnight system (ECL kit). at 48C. As previously described [18] the cell pellet was stained in PBS, pH 7.4, with addition of 0.1% (w / v) Triton X-100 (Sigma), 0.5 mM EDTA, pH 7.4, 0.05 mg / ml 2.10. Inhibition of cyclin A expression by RNase A (50 U / l, Sigma) and 50 mg / ml propidium iodide antisense-oligonucleotides (Boehringer Mannheim) at 48C overnight. A final con-6 centration of 10 cells / ml staining solution was achieved.
Endothelial cells were cultured in 100 ml of HAEC DNA content was analyzed from 10,000 cells (events) per medium in 96-well flat bottomed, fibronectin coated culgroup within the fluorescence gate using a Beckton Dickinture plates (Becton Dickinson). Cultures were seeded at 3 son Flow Cytometer in combination with the CytoFlow 6310 cells / well for subconfluent conditions. Antisense program version 2.2. CellFIT cell-cycle software from oligonucleotides (Biognostics, Heidelberg) were added at Becton Dickinson (Version 2.01.2) was used to determine 5-mM concentration to HAECs for 48-72 h, depending on the percentage of cells in G0 / G1, S or G2 / M phase. the experiment.
Flow cytometry for measurement of propidium 2.11. Statistical analysis iodide uptake
All values are expressed as mean6S.E.M., whether in Staining for propidium iodide uptake was performed as numbers or charted. Differences between groups were previously described [1] . In brief, pre-treated endothelial assessed by unpaired t-test (2 groups) or one-way ANOVA cells were washed twice with PBS and detached using (.2 groups). Subsequent multiple comparisons for $3 trypsin / 1 mM EDTA. Bovine serum albumin was added to groups were performed only if one-way ANOVA reached neutralize trypsin and cells were centrifuged for 5 min at statistical significance P,0.05, using the Student-New10003g. Following two more washing steps the cell pellet man-Keul's test to compare all pairs or Dunnett's post test was dissolved in 100 ml incubation buffer (10 ml 103 to compare each group against control. The level of binding buffer, 10 ml propidium iodide and 80 ml dH O).
statistical significance is indicated in each figure. Statistical 2 After 15-min incubation 400 ml 13binding buffer was calculations were carried out with GraphPad Prism version added and PI-fluorescence was measured recording 20,000 3.00 for Windows (GraphPad Software, San Diego Califorevents.
nia USA, www.graphpad.com).
Results
specific, since introduction of a dihydro-group into C2-or C6-ceramide completely abrogated its toxic effect (Fig.  3.1 . Role of cell density in ceramide-induced cell death 1B). Flowcytometric analysis of PI uptake is a marker for disruption of the cytoplasmic membrane, as seen in Ceramide toxicity was compared in subconfluent (6000 necrosis or later stages of apoptosis. While 10 mM of cells / well) versus confluent (40,000 cells / well) endotheli-C2-ceramide did not lead to a significant increase, 20 mM al cell layers. Concentrations of 10 mM and less had no and higher concentrations showed a more than 2-fold effect on cell viability, independent of cell density. Halfincrease in PI uptake by HAECs (P,0.01) (Fig. 2A) . To maximal cell death (LD ) was reached at 25 mM cerevaluate the morphology of cell nuclei under treatment 50 amide in subconfluent endothelial cells versus 75 mM in with ceramide, we performed DAPI staining. Control cells confluent cells (Fig. 1A) . Ceramide induced cell death was showed oval shaped nuclei with small nucleoli (Fig. 2B ) whereas C2-treated endothelial cells (30 mM) contained rounded, condensed nuclei with intense fluorescence (Fig.  2C) . 
independent of cell death any anti-proliferative effect.
[ H]Thymidine incorporation studies also showed significant inhibition of DNA synTo evaluate the effect of ceramide on endothelial cell thesis as early as 12 h after ceramide treatment (Fig. 3B) . growth, DNA synthesis was measured by two independent Conversely, primary toxic concentrations of C2-ceramide methods: BrdU-incorporation at 48 h was significantly (25 mM) also led to growth-inhibition measured after 48 h, inhibited at 6.25 mM (24%) and 12.5 mM (62%), while even when applied only for up to 2 h while no toxicity cell viability remained unchanged (Fig. 3A) . Dihydro-C2 could be shown in a parallel MTS assay from such short exposure (Fig. 4A ).
Loss of cyclin A leads to G1 cell-cycle arrest and subsequent growth-inhibition
We previously showed that TNF induced G1 cell-cycle arrest by downregulation of cyclin A. To evaluate whether ceramide induces growth arrest through similar mechanisms, we performed flow cytometric analysis of prop- idium-iodide stained cell samples. C2 treated HAECs quence, respectively (Fig. 5B,C) . BrdU-incorporation was demonstrated a significant increase in the G1 population reduced to 50% of control, while the scrambled sequence after 12 h (87 vs. 50%, P,0.0001) compared to untreated did not affect proliferation (P,0.001, Fig. 5D ). control cells. S-phase was also repressed with addition of C2 (5 vs. 42%, P,0.0001), proving growth-inhibition due to G1 cell-cycle arrest with C2 treatment (Fig. 4B) .
Phosphatase PP2A is involved in ceramide-mediated Western blot analysis revealed downregulation of cyclin A G1-arrest
Cip1 / Waf1 and p21 at 10-mM C2 concentration whereas other cell-cycle regulatory genes such as cyclin E, cdc2 or p53
Phosphatase PP2A can be activated by induction of remained unchanged at this concentration (Fig. 5A) . To stress and hence cause growth arrest in other cell systems. demonstrate that loss of cyclin A expression by itself is First we verified the existence of endogenous PP2A and its sufficient to cause growth arrest in human endothelial catalytic subunit PP2Ac in HAECs by Western blotting cells, we used antisense oligonucleotides with specific (data not shown). We used okadaic acid (OA), a protein sequences against cyclin A mRNA or a scrambled sephosphatase inhibitor, which has been shown to specifically inhibit PP2A at 1-nM concentration, while inhibition of other phosphatases required higher concentrations. OA was found to be a strong inducer of cell proliferation with maximum increase in BrdU-incorporation (143%) at 0.25 nM (Fig. 6A ). Concentrations higher than 1 nM caused opposite effects, leading to growth inhibition, most likely due to inhibition of other protein phosphatases. To find out whether PP2A induction by C2 was responsible for growth inhibition, we used increasing amounts of subtoxic ceramide concentrations in combination with 0.25 nM OA. Addition of 10 mM C2 abrogated the proliferative effect of 0.25 nM OA (45 vs. 146% cell number after 72 h, P,0.0001) (Fig. 6B ).
Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity
To investigate whether cyclin A was regulated throughout the cell-cycle in human endothelial cells, we synchronized cells in G1 phase with the phorbol ester PMA [19, 20] (Fig. 7A-C) or the CDK-inhibitor roscovitine [21] (Fig.  7B-C) . Both led to significant inhibition of BrdU-incorporation as well as cyclin A downregulation. Nocodazole arrested endothelial cells in G2 / M phase, as we showed previously [13] , and caused cyclin A downregulation (data not shown) accompanied by diminished BrdU-incorporation (Fig. 7B) . Aphidicolin treated HAECs accumulated in S-phase [13, 22] (Fig. 7A) and showed a 27% increase in BrdU-incorporation (Fig. 7B) together with significant upregulation of cyclin A protein expression (Fig. 7C) , demonstrating a tight connection between cyclin A expres- (Fig. 7C) . Finally, HAECs experiments is shown. *P,0.05 versus control; §P,0.01 versus control; NS, not significant. (B) HAECs were treated simultaneously with 1 nM of synchronized in G1-phase by roscovitine (Fig. 8A ) and okadaic acid and various C2 concentrations for 72 h. Relative cell PMA (Fig. 8B) showed a 3-to 5-fold increase in cell death number, as measured by the MTS assay, is indicated (control5100%).
with C2-ceramide treatment (P,0.001). In contrast, S-
The assay was performed with subconfluent HAECs in 96-well plates in phase synchronized HAECs were protected from C2-mesix wells per treatment group, and a representative of three experiments is diated cell death (6 vs. 17%, P,0.05) (Fig. 8C) .
shown. §P,0.01 versus cells treated with 1.0 nM okadaic acid. (A-C) HAECs were synchronized in G1 phase by 16-h pretreatment with 2.5 mg / ml roscovitine or 100 nM PMA, respectively, and in S-phase by 0.1 mg / ml aphidicolin. After medium exchange C2-ceramide was added at the indicated concentrations for 24 h and cell death was determined by the MTS assay. MTS assays were performed with subconfluent HAECs in 96-well plates. A representative of three experiments is shown (six wells per treatment group). Data are presented as mean6S.E.M., NS, not significant.
Discussion
dependent effect of ceramide on cell cycle progression in vascular endothelial cells, however, has never been ex-4.1. Ceramide-induced G1-arrest amined.
In this study we found that ceramide induces growth Ceramide, a product of regulated sphingomyelin hyarrest in human endothelial cells independent of its toxic drolysis, is released within minutes following stimulation effect. Cell death occurred at concentrations of 15 mM with tumor necrosis factor and has been implicated as a ceramide and higher in subconfluent HAECs, while at mediator of TNF-induced programmed cell death [15,23- subtoxic concentrations (#12.5 mM) ceramide only caused 25]. Beside its apoptotic effect, differences exist about the G1 cell-cycle arrest subsequent to cyclin A downregulainfluence of ceramide on cell proliferation [10, 26] . Though tion. it is likely that apoptosis results in growth-arrest, i.e.
Ceramide induced G1-arrest has been described by Cip1 / Waf1 through induction of p53 or p21 [4, 8] or simply others in yeast, human leukemia cells (HL-60 and MOLTdestruction of the nuclear cell-cycle machinery, an in-4) and a Wi38 fibroblast cell-line, but not in human primary cells [26] [27] [28] . The mechanisms for ceramide 4.3. Dependence of ceramide toxicity on cell cycle mediated G1 arrest in these models relied on two distinct regulation proteins: (a) in yeast, mutation of regulatory or catalytic subunits of a ceramide-activated protein phosphatase A potential link between cell proliferation and apoptosis (CAPP) abrogates the antiproliferative effect of ceramide has been suggested by the observation that several factors, [28] , and (b) in human leukemia cells ceramide blocked including adenovirus E1A and members of the E2F gene c-myc mRNA elongation as determined by nuclear run-on family, induce both cell cycle progression and apoptosis analysis [27] . Since Rudolph et al. identified a myc- [34] . In mice E2F can promote apoptosis and suppress responsive element in the cyclin A promoter [21] , this proliferation [35] . In previous work we demonstrated that could very well be one explanation for cyclin A downregu-E2F rescues endothelial cells from TNF-induced apoptosis lation as shown by our studies. In this context it is by restoration of cyclin A, thus overcoming G1-arrest [13] . noteworthy that ceramide concentrations used in the other Cyclin A is characterized by repression of its promoter studies to induce G1-arrest in mammalian cell lines were during the G1 phase of the cell cycle and its induction at also sufficient to induce apoptosis or cell death. This S-phase entry [36] [37] [38] . Furthermore, it can promote supports previous data showing a direct effect of TNF on adhesion-dependent cell cycle progression [39] . Our exthe cyclin A promoter [29] . 'Unspecific' cleavage of other periments confirm the unique role of cyclin A in S-phase cell-cycle regulatory proteins, such as p21, under apoptotic of endothelial cells, which notably are anchorage-depen-C2-concentrations can be explained by modulation of dent cells. In addition, S-phase cells were relatively caspase activity [30] .
protected from ceramide-induced cell death. Cyclin A seems therefore to be a possible contender for a cell-cycle dependent survival factor in endothelial cells. Our results 4.2. Role of protein phosphatase 2A demonstrated that (a) cyclin A is downregulated in G1 or G2 phase, (b) highly expressed in S-phase and (c) required C2-ceramide as well as naturally occurring ceramide for cell proliferation. Ceramide first leads to growth have been shown to activate a cytosolic protein phosphainhibition due to cyclin A downregulation. Further treattase in vitro, an effect denied to other related sphingolipids ment or higher concentrations then cause toxic effects, [28] . This ceramide activated protein phosphatase (CAPP) resembling the morphology of necrosis and apoptosis in seems to be a member of the 2A family of protein human endothelial cells. The toxic effect of ceramide can phosphatases (PP2A), all of which are heterotrimeric be enhanced by artificially keeping cyclin A levels low proteins comprised of a small catalytic subunit C, and two (PMA or roscovitine) and most importantly, toxicity can larger regulatory subunits, A and B [31] . Several PP2A be abrogated by overcoming ceramide-induced G1-arrest species exist in the cell, and although CAPP has not yet through prior synchronization of cells in S-phase with been identified at the molecular level, we demonstrate that aphidicolin. These findings strongly suggest that ceramide inhibiting PP2A with okadaic acid markedly increases can only develop its toxicity when cells are already in endothelial cell proliferation. Interestingly, this phenom-G1-phase and cyclin A levels are suppressed. These enon occurred only between 0.1-and 1.0-nM concenfindings suggest a strong bidirectional relationship between trations of okadaic acid while higher concentrations caused cell-cycle control and cell death in vessel biology. cell death. Okadaic acid is a polyketal fatty acid which can act as a strong tumor promoter [31, 32] . It binds to and inhibits PP1c and PP2Ac with dissociation constants (K )
